Cell Cycle/Checkpoint

The cell cycle is consisted of 4 main phases: Gap 1 (G1), DNA replication (S), Gap 2 (G2), and mitosis (M). There are “checkpoints” mechanism regulates the transition between these phases, at the G1/S boundary, in the S-phase and during G2/M phases. Cell can only pass through these checkpoints when signaling factors are activated and free of DNA damage. Important proteins that control cell cycle events and checkpoints are cullins, cyclins, cyclin-dependent kinases (Cdks), p53 and their inhibitors etc. Cdks family (Cdk2, Cdk3, Cdk4 and Cdk6) are Ser/Thr kinases that regulate cell cycle progression in association with cyclin binding partners (cyclin D, cyclin E and cyclin A) during all four phases. p53 halts the cell cycle if the DNA is damaged and allowing time for DNA repair to progress; it can also initiate apoptosis if DNA damage is too severe to be repaired.
-   B3386 Eribulin mesylateSummary: synthetic analogue of halichondrin B B3386 Eribulin mesylateSummary: synthetic analogue of halichondrin B
-   A4127 GSK1070916Target: Aurora KinasesSummary: Aurora B/C inhibitor A4127 GSK1070916Target: Aurora KinasesSummary: Aurora B/C inhibitor
-   A5700 BS-181 HClTarget: Cyclin-Dependent KinasesSummary: CDK7 inhibitor,highly selective A5700 BS-181 HClTarget: Cyclin-Dependent KinasesSummary: CDK7 inhibitor,highly selective
-   B3062 CW069Summary: allosteric inhibitor of HSET, selective B3062 CW069Summary: allosteric inhibitor of HSET, selective
-   A4126 Aurora A Inhibitor ITarget: Aurora KinasesSummary: Aurora A inhibitor A4126 Aurora A Inhibitor ITarget: Aurora KinasesSummary: Aurora A inhibitor
-   A5459 PHA-7938871 CitationTarget: Cyclin-Dependent KinasesSummary: Pan-Cdk inhibitor A5459 PHA-7938871 CitationTarget: Cyclin-Dependent KinasesSummary: Pan-Cdk inhibitor
-   B3058 CK-6361 CitationTarget: Arp2/3 complexSummary: Arp2/3 complex inhibitor B3058 CK-6361 CitationTarget: Arp2/3 complexSummary: Arp2/3 complex inhibitor
-   A4125 CYC116Target: Aurora Kinases|FLT3|VEGFRSummary: Potent Aurora A/B inhibitor A4125 CYC116Target: Aurora Kinases|FLT3|VEGFRSummary: Potent Aurora A/B inhibitor
-   A4467 SU 9516Summary: Cdk2 inhibitor A4467 SU 9516Summary: Cdk2 inhibitor
-   C5813 CFI-400945Summary: orally available, selective inhibitor of polo-like kinase 4 (PLK4) C5813 CFI-400945Summary: orally available, selective inhibitor of polo-like kinase 4 (PLK4)
